TELMISARTAN | A208605 | CADILA PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.1781
per ea
Lowest NADAC/Unit
$0.1098
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72241001704TELMISARTAN 80 MG TABLET | $0.1781 | EA | Generic | — | 2026-10-21 |
| 72241001722TELMISARTAN 80 MG TABLET | $0.1781 | EA | Generic | — | 2026-10-21 |
| 72241001604TELMISARTAN 40 MG TABLET | $0.1530 | EA | Generic | — | 2026-10-21 |
| 72241001622TELMISARTAN 40 MG TABLET | $0.1530 | EA | Generic | — | 2026-10-21 |
| 72241001504TELMISARTAN 20 MG TABLET | $0.1098 | EA | Generic | — | 2026-10-21 |
| 72241001522TELMISARTAN 20 MG TABLET | $0.1098 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.